Indefinite Delivery Contract HHSF223201310034I

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Lovelace Biomedical Research Institute with a potential value of $25 million. To date, two firm fixed price delivery orders have been awarded against the contract. Task Order 1, valued at $3.8 million, tasks Lovelace Biomedical Research Institute to determine if reductions in biomarkers of exposure and potential harm are proportional to reductions in cigarette smoking...

This indefinite delivery contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The $10 million master IDIQ contract, titled "Tobacco Products Pharmacology Study", is focused on regulatory and scientific efforts related to tobacco products under the FDA's purview. The contract has resulted in several firm fixed-price delivery orders to Battelle, valued at...

The Department of Health and Human Services Food and Drug Administration awarded a single award Indefinite Delivery Indefinite Quantity contract to Labstat International Inc. to provide tobacco laboratory analysis and engineering services. The contract has a potential value of $45 million over five one-year ordering periods. Three firm fixed price delivery orders have been awarded against the contract to date, including for new smoking regimen services generating and quantitating tobacco smoke...

The U.S. Food and Drug Administration (FDA), a civilian agency, awarded a $60 million single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the evaluation of the FDA's Center for Tobacco Products' (CTP) public health education campaigns and communication programs. This contract, which does not have a set-aside designation, has an ultimate completion date of August 29, 2026. Under this IDC, RTI has been awarded...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award $21 million indefinite delivery contract to Altasciences Clinical Kansas Inc., a contract research organization, to conduct pharmacokinetic and pharmacodynamic trials for medication development in substance use disorders. Under this contract, NIDA issued a $1,838,615 firm fixed price delivery order to Altasciences to perform Phase 1 cocaine drug interaction...

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to the non-profit Research Triangle Institute (RTI) International. The contract, valued up to $2,500,000, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract includes two firm fixed-price delivery orders issued to date. The first...

The National Cancer Institute (NCI) awarded a $74,995,000 multiple-award indefinite delivery/indefinite quantity (IDIQ) contract called the PREVENT Preclinical Drug Development Program to support preclinical pharmacology, toxicology, and product development services for cancer therapy candidates. The prime contractor, IIT Research Institute (IITRI), is a non-profit division of the Illinois Institute of Technology that specializes in these preclinical services for federal agencies. Under this...

The Blanket Purchase Agreement (BPA) awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Research Triangle Institute (RTI) International supports the procurement of technical and advisory services related to tobacco control policy evaluation. This single-award BPA, with a ceiling value of $9,500,000 and a period of performance through September 2025, allows the FDA to issue task orders for services such as technical guidance, assessments, data analysis, and...

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $6.5 million single-award Indefinite Delivery Contract (IDC) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to assess potential treatments for drug-induced respiratory depression and overdose toxicity. The contract has a period of performance from September 26, 2022 to September 25, 2027. Under this IDC, NIDA has issued several cost-plus-fixed-fee delivery...